ArticleBiomaterials2026
Click-crosslinked nanogels integrated into 3D stem cell spheroids enhance regenerative function for swallowing muscle repair.
Article in Biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Muscle injury or degeneration in the head and neck region can impair daily swallowing function. Mesenchymal stem cell (MSC) therapy has shown potential for muscle regeneration but faces challenges like poor cell survival and limited engraftment. Click-crosslinked nanogel-based hydrogels have emerged as promising cell delivery systems. This study introduces nanogel-microfiber fragments (NG-MF) as structural spacers within spheroids to enhance cell viability and function. By modifying cholesterol-bearing pullulan with acryloyl groups (CHPA) nanogels, we synthesized NG-MF using freeze-thaw cycles and sonication. NG-MF were then combined with adipose-derived MSCs (ADSCs) to fabricate hybrid spheroids. The NG-MF to ADSC ratio was optimized in hybrid spheroids, resulting in approximately a 5.6-fold increase in cell viability relative to cell-only spheroids. Hybrid spheroids also showed elevated secretion of key repair-associated factors, including interleukin (IL)-6, IL-10, and hepatocyte growth factor. This enhanced secretory function was maintained after the spheroids were refined to a smaller, injection-compatible size of approximately 100 μm for in vivo delivery. In rats with injured swallowing muscles, hybrid spheroid injection enhanced cell engraftment, reduced fibrosis, accelerated myogenin stabilization, and improved swallowing muscle function compared to cell-only spheroids. Cell engraftment rose by 20.8% from in vivo biodistribution analysis, and swallowing amplitude improved by 9.0% from electromyographic data three weeks post-treatment. The addition of NG-MF spacers in spheroids facilitates in situ injection-based delivery of ADSCs, thereby potentially enhancing in vivo swallowing muscle regeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.